ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Eight Firms Join AACR As Sustaining Members

April 25, 1997

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

House Members Express Support for Cancer Program

September 12, 1980

MRI Contract: AACI Group Still Seething

August 8, 1986

Pauling Contends His Applications Included Essentials

April 27, 1979

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978